|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.810
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.752
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.743
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.650
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.625
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.596
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.576
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.560
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.521
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.506
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.463
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.427
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.411
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.402
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.357
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.347
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.321
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.319
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.317
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.288
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.287
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.283
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.275
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.273
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.270
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.268
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.262
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.256
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.254
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.245
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.243
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.241
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.237
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.236
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.230
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.230
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.218
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.218
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.212
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.207
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.206
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.205
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.205
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.205
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.199
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.197
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.192
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.192
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.191
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.188
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.178
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.176
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.173
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.172
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.168
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.167
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.166
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.162
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.161
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.159
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.159
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.159
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.152
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.151
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.151
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.145
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.145
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.138
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.135
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.135
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.135
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.130
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.129
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.128
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.128
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.128
|
|
|
|
positive regulation of protein maturation
|
GO:1903319 |
7 |
0.127
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.126
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.125
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.124
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.123
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.122
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.122
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.120
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.117
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.116
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.113
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.112
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.112
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.111
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.111
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.110
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.109
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.109
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.108
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.108
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.107
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.105
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.105
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.105
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.104
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.103
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.102
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.102
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.100
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.099
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.096
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.096
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.096
|
|
|
|
plasminogen activation
|
GO:0031639 |
7 |
0.096
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.095
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.093
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.093
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.092
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.092
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.091
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.091
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.091
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.090
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.090
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.088
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.088
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.088
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.087
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.086
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.085
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.082
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.082
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.082
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.081
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.081
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.081
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.081
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.080
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.080
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.080
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.079
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.079
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.079
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.077
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.077
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.076
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.076
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.076
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.076
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.074
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.074
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.074
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.073
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.073
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.073
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.073
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.072
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.071
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.071
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.071
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.070
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.070
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.069
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.069
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.069
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.068
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.068
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.067
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.067
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.066
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.066
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.065
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.065
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.065
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.064
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.064
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.063
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.063
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.063
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.062
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.062
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.061
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.061
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.060
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.060
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.060
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.060
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.060
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.060
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.060
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.059
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.059
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.059
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.059
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.058
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.058
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.058
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.057
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.057
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.056
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.056
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.056
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.056
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.056
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.056
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.055
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.055
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.055
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.055
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.054
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.054
|
|
|
|
regulation of branching involved in salivary gland morphogenesis
|
GO:0060693 |
11 |
0.054
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.054
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.054
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.053
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.053
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.053
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.053
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.053
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.053
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.052
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.052
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.051
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.051
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.051
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.051
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.050
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.049
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.049
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.049
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.049
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.048
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.048
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.048
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.048
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.048
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.048
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.048
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.047
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.047
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.047
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.047
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.047
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.047
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.047
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.047
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.046
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.046
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.046
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.046
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.045
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.045
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.045
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.045
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.045
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.044
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.044
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.044
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.044
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.044
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.043
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.043
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.043
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.043
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.043
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.043
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.042
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.042
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.042
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.042
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.042
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.042
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.042
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.042
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.042
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.042
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.041
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.041
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.041
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.041
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.041
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.041
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.041
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.041
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.040
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.040
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.040
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.040
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.040
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.040
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.040
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.040
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.040
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.040
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.040
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.040
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.039
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.039
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.039
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.039
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.039
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.039
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.039
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.038
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.038
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.038
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.038
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.038
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.038
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.038
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.037
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.037
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.037
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.037
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.036
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.036
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.036
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.036
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.036
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.036
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.035
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.035
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.035
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.035
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.035
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.034
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.034
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.034
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.034
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.033
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.033
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.033
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.033
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.033
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.032
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.032
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.032
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.032
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.032
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.032
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.032
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.032
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.032
|
|
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.032
|
|
|
|
folic acid containing compound metabolic process
|
GO:0006760 |
3 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.032
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.032
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.032
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.032
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.032
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.032
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.031
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.031
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.031
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.031
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.031
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.031
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.031
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.031
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.031
|
|
|
|
mesenchymal cell differentiation involved in lung development
|
GO:0060915 |
2 |
0.031
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.031
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.031
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.031
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.031
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.031
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.031
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.030
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.030
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.030
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.030
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.030
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.030
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.030
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.030
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.030
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.030
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.030
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.030
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.029
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.029
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.029
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.029
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.029
|
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.029
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.029
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.029
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.029
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.029
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.029
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.029
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.029
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.029
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.029
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.029
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.029
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.028
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.028
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.028
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.028
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.028
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.028
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.028
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.028
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.028
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.028
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.028
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.028
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.028
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.028
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.027
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.027
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.027
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.027
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.027
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.026
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.026
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.026
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.026
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.026
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.026
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.026
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.026
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.026
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
10 |
0.026
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.026
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.026
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.026
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.026
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.026
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.026
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.025
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.025
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.025
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.025
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.025
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.025
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.025
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.025
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.025
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.025
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.025
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.025
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.025
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.025
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.025
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.025
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
12 |
0.024
|
|
|
|
lateral mesoderm morphogenesis
|
GO:0048369 |
3 |
0.024
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.024
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.024
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.024
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.024
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.024
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.024
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.024
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.024
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.024
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.024
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.024
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.024
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.024
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.023
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.023
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.023
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.023
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.023
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.023
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.023
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.023
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.023
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.023
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.023
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.022
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.022
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.022
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.022
|
|
|
|
positive regulation of blood coagulation
|
GO:0030194 |
10 |
0.022
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.022
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.022
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.022
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.022
|
|
|
|
connective tissue replacement involved in inflammatory response wound healing
|
GO:0002248 |
3 |
0.022
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.022
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.022
|
|
